When AI meets a deeply human problem: How AI is transforming medical literature monitoring

A family where medicine and technology meet 

Growing up, dinner table conversations in my house looked a little different.

My mother was a gynecologist, and healthcare has always been part of my family. My sister and brother-in-law are gynecologists, and now my nieces are studying medicine. On the other hand, all of my children chose Computer Science.

Medicine and technology have become two threads running through my family.

Surrounded by medicine from an early age, I learned that healthcare isn't just an industry. It's deeply human. Today, surrounded by technology as well, I see the extraordinary opportunity that exists when those two worlds come together.

Why up-to-date medical evidence matters for patient care 

I also learned how important it is for physicians to have access to the latest evidence about the medicines they prescribe, including new findings about safety, risks, and potential adverse effects.

In areas like women's health and hormone therapies, that evidence can directly influence clinical decisions and patient care. A new study on side effects or drug interactions can change how a physician treats a patient. That means the speed at which evidence travels from a research paper to a doctor's office is not an abstract problem. It affects real people.

The challenge: too much medical literature, not enough time 

Years later, looking at healthcare through the lens of a Software Engineer, I see that same challenge at a completely different scale.

Pharmaceutical companies need to continuously monitor and evaluate enormous volumes of scientific literature to identify relevant evidence about their therapies. This process, known as literature monitoring, is a core part of pharmacovigilance: the science of detecting, assessing, and preventing adverse effects of medicines. It is also a regulatory obligation in many markets. 

The challenge isn't a lack of information. It's being able to find, process, and act on the right evidence fast enough. Thousands of new articles are published every week, and many are duplicated across databases. Each one has to be screened, classified, and assessed by qualified experts. Done manually, this work is slow, repetitive, and hard to scale.

How AI automates medical literature review 

And that's why I'm particularly proud of the work our team at Darwoft is doing.

We are helping build technology that uses AI to streamline the medical literature workflow from start to finish:

• Ingestion: automatically collecting new publications from scientific and medical sources.

• Deduplication: identifying and removing duplicate records, so experts don't review the same article twice.

• Classification: sorting complex medical literature by relevance, so the most important evidence surfaces first.

• Summarization: generating critical summaries that help medical teams work with evidence faster and meet regulatory requirements.

The goal isn't to replace medical experts. It's to remove the repetitive burden so they can focus their time and judgment on what matters most: evaluating the evidence. 

Why accuracy, traceability, and trust matter in Life Sciences AI 

In Life Sciences, speed alone isn't enough. Accuracy, traceability, and trust matter just as much.

Every decision an AI system supports needs to be explainable and auditable. Medical teams and regulators must be able to see where information came from, how it was classified, and why. That's why building AI for healthcare requires more than strong models. It requires careful software engineering, validated processes, and a deep respect for the people who depend on the results.

Why this work matters to me 

As a Software Engineer, I'm excited by what we can build with AI.

As a patient, knowing that technology can help critical medical evidence move faster, from clinical and scientific literature to the physicians making decisions at the point of care, gives me peace of mind.

And as the daughter of a physician, seeing technology reduce the burden of processing complex medical evidence makes this work particularly meaningful to me.

From my leadership role and technical background, my commitment has always been clear:

Build software that delivers real, measurable value to society.

Ultimately, this is about more than processing information faster. It's about reducing the distance between scientific evidence and better patient outcomes.